Memorial Göztepe Hospital
Memorial Göztepe Hospital
Turkey, Istanbul
No hidden fees – just official clinic prices. Pay at the clinic for Immunotherapy treatment and use a flexible instalment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Immunotherapy treatment and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Immunotherapy treatment journey.
Dr. Zafer Gulbas founded and directs Turkey’s largest Bone Marrow Transplant Center at Anadolu Medical Center. He is a hematologist-oncologist specializing in complex blood cancers and clotting disorders. Dr. Gulbas trained at top global institutions, including MD Anderson and Fred Hutchinson in the USA. He performs autologous and allogeneic transplants for leukemia, lymphoma, and aplastic anemia.
Dr. Bulent Karagoz is a medical oncologist at Anadolu Medical Center in Istanbul. He specializes in immunotherapy and targeted therapies for sarcoma, lymphoma, and lung cancer. Dr. Karagoz provides treatment at a facility affiliated with the prestigious Johns Hopkins Hospital.
Dr. Huseyin Baloglu is a pathologist at Anadolu Medical Center in Turkey. He leads liquid biopsy and precision oncology services. Dr. Baloglu holds a patent for molecular diagnostics in thyroid cancer treatment. He completed training at Albert Einstein College of Medicine and Heidelberg University.
Dr. Sinan Karaaslan is a medical oncologist at Anadolu Medical Center in Istanbul. He specializes in treating breast, colorectal, and urogenital system cancers. Dr. Karaaslan brings clinical expertise from major institutions, including Medical Park and Gülhane Military Medical Academy. He works at a hospital affiliated with the Johns Hopkins Hospital.
Patients can definitely send medical records for a remote second opinion before travelling to Turkey. JCI-accredited centres like Hisar Hospital Intercontinental and SANKO University Hospital routinely coordinate these reviews. Specialists use digital scans and pathology reports to confirm if immunotherapy is suitable before travel.
Bookimed Expert Insight: Turkish oncology centres often use multidisciplinary tumour boards for remote reviews. At Anadolu Medical Center, medical oncologists like Dr Bulent Karagoz work with pathology experts like Dr Huseyin Baloglu. This means the immunotherapy plan aligns with precision molecular diagnostics before the patient arrives.
Patient Consensus: Patients note that record reviews often change treatment plans, so it is vital to send everything up front. They suggest getting independent written opinions first to verify the diagnosis before committing to international travel.
Leading Turkish hospitals and oncologists hold rigorous international certifications. These are from Joint Commission International and the European Society for Medical Oncology. Specialists often train at top-tier institutions like MD Anderson. Facilities follow evidence-based protocols using globally approved drugs like Keytruda to maintain high safety standards.
Bookimed Expert Insight: Turkish oncology expertise is highly concentrated in Istanbul. Specialists like Dr Zafer Gulbas and Dr Seref Komurcu hold dual certifications from US and European bodies. This density of qualified doctors allows hospitals to run multidisciplinary tumour boards. These boards vet every case so that patients actually benefit from expensive immunotherapy agents.
Patient Consensus: Patients note it is important to verify that a facility is a full-scale hospital. They emphasise checking if immunotherapy is supervised in-house by board-certified oncologists in Turkey. Practical wisdom suggests confirming official Health Ministry authorisation. It also suggests confirming specialist backup for managing side effects before travel.
Turkish oncology centres use immunotherapy to treat advanced lung cancer, melanoma, kidney cancer, and bladder cancer. Clinics also apply these biological therapies for triple-negative breast cancer and gastric tumours. Specialised departments in Istanbul and Ankara deploy cellular therapies for lymphomas and specific leukaemias.
Bookimed Expert Insight: Turkish oncology professors, such as Dr Seref Komurcu and Dr Necdet Uskent at Anadolu Medical Center, often combine immunotherapy like Keytruda with precision molecular profiling. These centres are affiliated with Johns Hopkins Medicine. Data shows they use liquid biopsies to track cancer DNA in blood. This helps specialists adjust biological dosages based on real-time genetic changes rather than just physical scans.
Patient Consensus: Patients in Turkey report significant tumour reduction in non-small cell lung cancer cases after combining chemotherapy with immunotherapy. Families note that major Istanbul hospitals provide access to personalised cancer vaccines and clinical trials for advanced stage 4 conditions.
Eligibility for immunotherapy in Turkey depends on a remote medical evaluation of your diagnostic profile. Specialists review pathology reports and biomarker results, such as PD-L1 expression or Microsatellite Instability (MSI). They confirm treatment only after this review. This assessment matches the chosen drug to your cancer type and physical health.
Bookimed Expert Insight: Turkish oncology centres often use multidisciplinary tumour boards to review complex cases. Leading doctors like Dr. Bulent Karagoz and Dr. Seref Komurcu maintain high standards. They work at Anadolu Medical Center, which is affiliated with Johns Hopkins Medicine. This collaboration gives patients access to global treatment protocols. It also provides precision tools like Watson for Oncology for personalised planning.
Patient Consensus: Patients note that eligibility depends strictly on tumour details rather than travel plans. Many find it helpful to secure a medical review before booking flights. This confirms drug availability and helps manage out-of-pocket costs.
Turkish oncology centres routinely combine immunotherapy with chemotherapy, targeted therapy, and radiation. Specialists at JCI-accredited facilities like Anadolu Medical Center use multidisciplinary boards to sequence these treatments. High-precision tools like MR Linac and CyberKnife often support systemic immune responses during combination protocols.
Bookimed Expert Insight: While many patients focus on drug combinations, Turkey's strength lies in integration with local therapies. Professors such as Dr Zafer Gulbas at Anadolu Medical Center oversee bone marrow transplants alongside immunotherapy. This multidisciplinary depth is why clinics here manage 3,000+ complex procedures annually with high success.
Patient Consensus: Patients in Turkey find that immunotherapy is often paired with local procedures like cryoablation or targeted drugs. They note it is vital to confirm whether treatments happen concurrently or in a specific sequence.
Patients visiting Turkey for immunotherapy typically experience few communication hurdles in major private hospitals. These facilities employ multilingual coordinators and specialists. They often train in the United Kingdom or United States. Dedicated international departments provide medical interpreters to translate during consultations and consent discussions.
Bookimed Expert Insight: Many doctors like Prof Dr Seref Komurcu hold international certifications from the USA or Europe. However, nursing staff on night shifts may have limited English. Bookimed data suggests choosing clinics in Istanbul, like Anadolu Medical Center. There, oncology teams are specifically structured to support diverse international populations from Europe and the USA.
Patient Consensus: Patients note that larger private hospitals in Istanbul offer smooth experiences. However, they recommend confirming that discharge paperwork and adverse-effect instructions are provided in English. The Turkish Ministry of Health also offers a 24/7 translation hotline. It provides instant support for medical tourists if in-person communication becomes difficult.